Skip to main content
Signal8

MATSUI CONNIE

SEC insider (Form 3/4/5 filer). CIK 0001236537. Director at ARTELO BIOSCIENCES, INC. (ARTL) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jul 17, 2026. Located in SOLANA BEACH, CA.

Companies MATSUI CONNIE has filed insider reports for

  • ARTELO BIOSCIENCES, INC. (ARTL): Director
  • SUTRO BIOPHARMA, INC. (STRO): Director
  • HALOZYME THERAPEUTICS, INC. (HALO): Director
MATSUI CONNIE profile photo

MATSUI CONNIE

CIK: 0001236537

Transaction Breakdown

Open Market Buys (P)2 (15.4%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (46.2%)

Compensation grants

Other (G, F, J, C, D, …)5 (38.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ARTELO BIOSCIENCES, INC. logo
ARTL

ARTELO BIOSCIENCES, INC.

Director
SUTRO BIOPHARMA, INC. logo
STRO

SUTRO BIOPHARMA, INC.

Director
HALOZYME THERAPEUTICS, INC. logo
HALO

HALOZYME THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Jul 17, 2026
    Award

    Stock Option (right to buy)

    Direct
    136 shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Jun 5, 2026
    Award

    Stock Option (right to buy)

    Direct
    10K shares-
  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Jan 30, 2026
    Award

    Stock Options (right to buy)

    Direct
    292 shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Dec 23, 2025
    Award

    Stock Option (right to buy)

    Direct
    1.5K shares-
  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Oct 28, 2025
    Conversion

    Warrant (right to buy)

    Direct
    38.3K shares-
  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Oct 28, 2025
    Conversion

    Convertible Promissory Note

    Direct
    0 shares at avg. $110843.00-
  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Oct 28, 2025
    Conversion

    Warrant (right to buy)

    Direct
    70.4K shares-
  • ARTELO BIOSCIENCES, INC. logo
    ARTL

    ARTELO BIOSCIENCES, INC.

    Oct 28, 2025
    Conversion

    Convertible Promissory Note

    Direct
    0 shares at avg. $140000.00-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Oct 15, 2025
    Purchase
    Direct
    50K shares at avg. $0.80$40K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Jun 6, 2025
    Award

    Stock Option (right to buy)

    Direct
    50K shares-

1-10 of 13